Preventing secondary cancer

It’s early days, but Tel Aviv University scientists have managed in lab tests to reduce the incidence of breast cancer relapse by 88%. They used two chemotherapies – doxorubicin and cisplatin together, which reduced the spread of cancer cells (metastasis) that occurred using just one therapy.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *